It has been a year since Mary Till joined Finnegan as of counsel. To reflect on her year, Mary spoke with Managing Intellectual Property and shared how she is applying her nearly 20 years of experience at the United States Patent and Trademark Office to her role and how it has shaped her practice.
Mary said she has helped many pharma and biotech clients with strategic analysis of their portfolios for the purpose of obtaining a Patent Term Extension (PTE) – an area she worked on at the agency. Patent owners can obtain a PTE to make up for time lost while awaiting regulatory review of their products. Till was involved in around 400 or 500 PTE cases while at the agency, she said.
“My knowledge and expertise in that area make it something that people seek me out for when they have questions,” Mary said. “If an application gets stuck somewhere and isn’t going along the path it’s supposed to be, I pretty much know how to fix that.”
Read “How Former USPTO Advisor Is Using Her Expertise at Finnegan”
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say
September 17, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.